Unilever’s Baby Dove wash and lotion has fallen foul of guidelines set by the UK’s ad watchdog, which ruled the product does not benefit the skin microbiome, unless proof
can be presented.
In the ruling dated 13 Jan 2021, The Advertising Standards Authority (ASA) stated the social media ad, used a series of statements suggesting the product could “nourish” a baby’s skin microbiome.
Responding to accusations the ad was misleading and could not be substantiated, Unilever said the claims did not state or imply the products could be used to make a medical diagnosis or treat or prevent disease, including injury, ailment or adverse condition.
By Will Chu – 12 Jan 2021
Roger Guillemin identified the molecules in the brain that control the production of hormones in…
In 2007, Sinclair wrote the article “Healthy Hair: What is it?” in which he stated,…
We spoke to John Chave, director-general at trade body Cosmetics Europe, about changing regulations, what’s…